Skip to main content

Cartilage Tumours of Bone

  • Reference work entry
  • First Online:
European Surgical Orthopaedics and Traumatology

Abstract

Cartilaginous tumours form the second largest group of primary bone tumours. They all share the characteristic production of chondroid matrix by tumour cells. Cartilage tumours range from completely benign lesions to highly malignant and are sub-divided by location in intramedullary, central and surface or peripheral sites. Most cartilage lesions can be diagnosed using plain radiographs or MRI. Differentiation between benign and malignant can be very difficult, for example enchondroma versus low-grade chondrosarcoma, osteochondroma versus peripheral chondrosarcoma and chondroblastoma versus clear-cell chondrosarcoma. Biopsy of malignant lesions can be false negative due to sample error as most cartilage lesions have grades of malignancy and can even present benign sections.

Benign lesions are best left untouched if free of symptoms and radiologically inactive such as enchondroma of the phalanges. En bloc resection of osteochondroma including the pseudocapsule is curative and results in a very low recurrence rate.

Malignant cartilage tumours, if low-grade central chondrosarcoma of the long bones, can be treated with intralesional surgery in combination with some adjuvant (phenol, cryosurgery). High grade chondrosarcoma (including clear-cell chondrosarcoma) and all chondrosarcoma of the axial skeleton should be surgically resected with wide margins with an intermediate risk of local recurrence.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 649.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 949.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Ahmad S, Shen FH, Bleyer WA. Methotrexate-induced renal failure and ineffectiveness of peritoneal dialysis. Arch Intern Med. 1978;138:1146–7.

    Article  CAS  PubMed  Google Scholar 

  2. Bertoni F, Bacchini P. Classification of bone tumors. Eur J Radiol. 1998;27 Suppl 1:S74–6.

    Article  PubMed  Google Scholar 

  3. Bjornsson J, McLeod RA, Unni KK, Ilstrup DM, Pritchard DJ. Primary chondrosarcoma of long bones and limb girdles. Cancer. 1998;83:2105–19.

    Article  CAS  PubMed  Google Scholar 

  4. Bovee JV, Hogendoorn PC, Wunder JS, Alman BA. Cartilage tumours and bone development: molecular pathology and possible therapeutic targets. Nat Rev Cancer. 2010;10:481–8.

    Article  CAS  PubMed  Google Scholar 

  5. Bovee JV, Cleton-Jansen AM, Rosenberg C, Taminiau AH, Cornelisse CJ, Hogendoorn PC. Molecular genetic characterization of both components of a dedifferentiated chondrosarcoma, with implications for its histogenesis. J Pathol. 1999;189:454–62.

    Article  CAS  PubMed  Google Scholar 

  6. Cesari M, Bertoni F, Bacchini P, Mercuri M, Palmerini E, Ferrari S. Mesenchymal chondrosarcoma. An analysis of patients treated at a single institution. Tumori. 2007;93:423–7.

    PubMed  Google Scholar 

  7. Fletcher CDM, Krishnan Unni K, Fredrik Mertens. World health organization classification of tumours pathology and genetics of tumours of soft tissue and bone. Lyon: IARC Press; 2002.

    Google Scholar 

  8. Coughlan B, Feliz A, Ishida T, Czerniak B, Dorfman HD. p53 Expression and DNA ploidy of cartilage lesions. Hum Pathol. 1995;26:620–4.

    Article  CAS  PubMed  Google Scholar 

  9. Dantonello TM, Int-Veen C, Leuschner I, et al. Mesenchymal chondrosarcoma of soft tissues and bone in children, adolescents, and young adults: experiences of the CWS and COSS study groups. Cancer. 2008;112:2424–31.

    Article  PubMed  Google Scholar 

  10. Dickey ID, Rose PS, Fuchs B, et al. Dedifferentiated chondrosarcoma: the role of chemotherapy with updated outcomes. J Bone Joint Surg Am. 2004;86-A:2412–8.

    PubMed  Google Scholar 

  11. Donati D, Yin JQ, Colangeli M, et al. Clear cell chondrosarcoma of bone: long time follow-up of 18 cases. Arch Orthop Trauma Surg. 2008;128:137–42.

    Article  PubMed  Google Scholar 

  12. Eefting D, Schrage YM, Geirnaerdt MJ, et al. Assessment of interobserver variability and histologic parameters to improve reliability in classification and grading of central cartilaginous tumors. Am J Surg Pathol. 2009;33:50–7.

    Article  PubMed  Google Scholar 

  13. van der Eijken JW, van der Heul RO, Mulder JD, et al. Wegwijzer tumoren van het skelet. Leiden: Commissie voor Beentumoren; 1987.

    Google Scholar 

  14. Evans HL, Ayala AG, Romsdahl MM. Prognostic factors in chondrosarcoma of bone: a clinicopathologic analysis with emphasis on histologic grading. Cancer. 1977;40:818–31.

    Article  CAS  PubMed  Google Scholar 

  15. Geirnaerdt MJ, Hogendoorn PC, Bloem JL, Taminiau AH, van der Woude HJ. Cartilaginous tumors: fast contrast-enhanced MR imaging. Radiology. 2000;214:539–46.

    Article  CAS  PubMed  Google Scholar 

  16. Gelderblom H, Hogendoorn PC, Dijkstra SD, et al. The clinical approach towards chondrosarcoma. Oncologist. 2008;13:320–9.

    Article  PubMed  Google Scholar 

  17. Grimer RJ, Gosheger G, Taminiau A, et al. Dedifferentiated chondrosarcoma: prognostic factors and outcome from a European group. Eur J Cancer. 2007;43:2060–5.

    Article  PubMed  Google Scholar 

  18. Grote HJ, Schneider-Stock R, Neumann W, Roessner A. Mutation of p53 with loss of heterozygosity in the osteosarcomatous component of a dedifferentiated chondrosarcoma. Virchows Arch. 2000;436:494–7.

    Article  CAS  PubMed  Google Scholar 

  19. Hallor KH, Staaf J, Bovee JV, et al. Genomic profiling of chondrosarcoma: chromosomal patterns in central and peripheral tumors. Clin Cancer Res. 2009;15:2685–94.

    Article  CAS  PubMed  Google Scholar 

  20. Hopyan S, Gokgoz N, Poon R, et al. A mutant PTH/PTHrP type I receptor in enchondromatosis. Nat Genet. 2002;30:306–10.

    Article  PubMed  Google Scholar 

  21. Lack W, Lang S, Brand G. Necrotizing effect of phenol on normal tissues and on tumors. A study on postoperative and cadaver specimens. Acta Orthop Scand. 1994;65:351–4.

    Article  CAS  PubMed  Google Scholar 

  22. Leerapun T, Hugate RR, Inwards CY, Scully SP, Sim FH. Surgical management of conventional grade I chondrosarcoma of long bones. Clin Orthop Relat Res. 2007;463:166–72.

    PubMed  Google Scholar 

  23. Maffucci A. Di un caso encondroma ed angioma multiplo. Movimento medico-chirurgico 1881;3:399-412-565-575.

    Google Scholar 

  24. Mirra JM, Gold R, Downs J, Eckardt JJ. A new histologic approach to the differentiation of enchondroma and chondrosarcoma of the bones. A clinicopathologic analysis of 51 cases. Clin Orthop Relat Res. 1985;Dec(201):214–37.

    Google Scholar 

  25. Nakashima Y, Unni KK, Shives TC, Swee RG, Dahlin DC. Mesenchymal chondrosarcoma of bone and soft tissue. A review of 111 cases. Cancer. 1986;57:2444–53.

    Article  CAS  PubMed  Google Scholar 

  26. Ollier M. Dyschondroplasie. Lyon Med. 1900;93:23–5.

    Google Scholar 

  27. Pansuriya TC, Kroon HM, Bovee JV. Enchondromatosis: insights on the different subtypes. Int J Clin Exp Pathol. 2010;3:557–69.

    PubMed Central  PubMed  Google Scholar 

  28. Persson BM, Wouters HW. Curettage and acrylic cementation in surgery of giant cell tumors of bone. Clin Orthop Relat Res. 1976;Oct(120):125–33.

    Google Scholar 

  29. Ropke M, Boltze C, Neumann HW, Roessner A, Schneider-Stock R. Genetic and epigenetic alterations in tumor progression in a dedifferentiated chondrosarcoma. Pathol Res Pract. 2003;199:437–44.

    Article  CAS  PubMed  Google Scholar 

  30. Rozeman LB, Hameetman L, van Wezel T, et al. CDNA expression profiling of chondrosarcomas: ollier disease resembles solitary tumours and alteration in genes coding for components of energy metabolism occurs with increasing grade. J Pathol. 2005;207:61–71.

    Article  CAS  PubMed  Google Scholar 

  31. Stickens D, Brown D, Evans GA. EXT genes are differentially expressed in bone and cartilage during mouse embryogenesis. Dev Dyn. 2000;218:452–64.

    Article  CAS  PubMed  Google Scholar 

  32. Verdegaal SH, Corver WE, Hogendoorn PC, Taminiau AH. The cytotoxic effect of phenol and ethanol on the chondrosarcoma-derived cell line OUMS-27: an in vitro experiment. J Bone Joint Surg Br. 2008;90:1528–32.

    Article  CAS  PubMed  Google Scholar 

  33. Veth R, Schreuder B, van Beem H, Pruszczynski M, de Rooy J. Cryosurgery in aggressive, benign, and low-grade malignant bone tumours. Lancet Oncol. 2005;6:25–34.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Antonie H. M. Taminiau .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 EFORT

About this entry

Cite this entry

Taminiau, A.H.M., Bovée, J.V.M.G., van Rijswijk, C.S.P., Gelderblom, H.A.J., van de Sande, M.A.J. (2014). Cartilage Tumours of Bone. In: Bentley, G. (eds) European Surgical Orthopaedics and Traumatology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-34746-7_206

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-34746-7_206

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-34745-0

  • Online ISBN: 978-3-642-34746-7

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics